About
Technology
Issues
FAQ
Links
Official Page
Evaluation of baseline asymptomatic dysimmunity prevalence in cancer patients receiving monoclonal anti-PD1 antibodies.
site/software ©
exaly
; All materials licenced under
CC by-SA
.